International Stem Cell (ISCO) Net Income (2010 - 2026)
International Stem Cell's (ISCO) quarterly Net Income came in at -$69000.0 in Q2 2026, down 153.49% year-over-year from $129000.0 in Q2 2025, and up 80.17% quarter-over-quarter from -$348000.0 in Q4 2025.
Powered by 
Analysis
International Stem Cell (ISCO) Net Income (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Net Income for 17 consecutive years, with -$69000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income fell 153.49% year-over-year to -$69000.0 in Q2 2026; TTM through Jun 2026 was -$231000.0, a 3.75% increase from a year earlier, with the FY2025 full-year figure at -$418000.0, down 96.24% from the prior year.
- Net Income was -$69000.0 for Q2 2026 at International Stem Cell, up from -$348000.0 in the prior quarter.
- Over five years, Net Income peaked at $129000.0 in Q2 2025 and troughed at -$458000.0 in Q4 2023.
- A 5-year average of -$107058.8 and a median of -$69000.0 in 2026 frame the typical range for Net Income.
- Across the five-year window, Net Income plunged 8850.0% in 2023 and jumped 163.69% in 2024, its largest moves.
- Over 5 years, Net Income stood at $28000.0 in 2022, then tumbled by 1735.71% to -$458000.0 in 2023, then surged by 102.62% to $12000.0 in 2024, then sank by 3000.0% to -$348000.0 in 2025, then soared by 80.17% to -$69000.0 in 2026.
- The last three Net Income figures came in at -$69000.0 (Q2 2026), -$348000.0 (Q4 2025), and $57000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 54.77 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -91.19 Mn |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | -47.29 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 77.80 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | -81.06 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -119.07 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 20.07 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.39 Bn | 251.87 Mn | -4.89 Mn |
| 9 | Vericel | 1.96 Bn | 1.79 Bn | 56.40 Mn | 2.23 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | -69,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69,000.00 |
| Dec 31, 2025 | -348,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -125,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | -214,000.00 |
| Dec 31, 2023 | -458,000.00 |
| Sep 30, 2023 | -131,000.00 |
| Jun 30, 2023 | -179,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | -335,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | -364,000.00 |
| Sep 30, 2021 | -641,000.00 |
| Jun 30, 2021 | -445,000.00 |